Literature DB >> 20150612

Direct effects of delta opioid receptor agonists on invasion-associated activities of HCT-8/E11 colon cancer cells.

Delphine Debruyne1, Ancy Leroy, Olivier DE Wever, Luc Vakaet, Marc Mareel, Marc Bracke.   

Abstract

BACKGROUND: Opioids and opioid receptors are an integral part of the tumour microenvironment and hence may influence tumour progression. Studies on direct effects of opioids on invasion-associated cellular activities are equivocal. We wanted to clarify these differences.
MATERIALS AND METHODS: The direct effects of the delta opioid receptor (DOR) agonists [D-Pen(2), D-Pen(5)]-enkephalin (DPDPE), leu-enkephalin and [D-Ala(2), D-Leu(5)]-enkephalin (DADLE) on invasion-associated activities of HCT-8 myc-DOR and HCT-8 FLAG-DOR colon cancer cells stably overexpressing DOR were studied.
RESULTS: The opioids showed a trend to stimulate invasion of single cells in collagen in one clone, while they did not influence invasion of the other clone. In other invasion assays, no effects were observed. They did not affect cell growth and homotypical cell-cell adhesion. DPDPE at 0.1 muM inhibited directional migration; the other opioids and concentrations tested were inefficient.
CONCLUSION: Opioids differently influence invasion-associated cellular activities, depending on the expression level of DOR, experimental set-up, type and concentration of opioid.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150612

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Chitosan nanoparticles are efficient carriers for delivering biodegradable drugs to neuronal cells.

Authors:  M Malatesta; V Galimberti; B Cisterna; M Costanzo; M Biggiogera; C Zancanaro
Journal:  Histochem Cell Biol       Date:  2013-12-20       Impact factor: 4.304

2.  Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.

Authors:  Amanda Shanks Huynh; Veronica Estrella; Valerie E Stark; Allison S Cohen; Tingan Chen; Todd J Casagni; Jatinder S Josan; Mark C Lloyd; Joseph Johnson; Jongphil Kim; Victor J Hruby; Josef Vagner; David L Morse
Journal:  Mol Pharm       Date:  2016-01-08       Impact factor: 4.939

3.  Spinal activation of delta opioid receptors alleviates cancer-related bone pain.

Authors:  V Otis; P Sarret; L Gendron
Journal:  Neuroscience       Date:  2011-03-31       Impact factor: 3.590

4.  Inhibition of δ-opioid receptors induces brain glioma cell apoptosis through the mitochondrial and protein kinase C pathways.

Authors:  Lixiang Zhou; Xudong Guo; Mo Chen; Shuanglin Fu; Jingbin Zhou; Gang Ren; Zirong Yang; Wenhai Fan
Journal:  Oncol Lett       Date:  2013-08-26       Impact factor: 2.967

5.  The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer.

Authors:  Frances E Lennon; Tamara Mirzapoiazova; Bolot Mambetsariev; Valeriy A Poroyko; Ravi Salgia; Jonathan Moss; Patrick A Singleton
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

6.  microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway.

Authors:  Yi Zhang; Yangchao Wei; Xuan Li; Xingsi Liang; Liming Wang; Jun Song; Xiuzhong Zhang; Chong Zhang; Jian Niu; Pengbo Zhang; Zeqiang Ren; Bo Tang
Journal:  Cell Death Dis       Date:  2018-01-26       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.